Compare BBSI & CYRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BBSI | CYRX |
|---|---|---|
| Founded | 1965 | 1999 |
| Country | United States | United States |
| Employees | N/A | 1100 |
| Industry | Professional Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 818.9M | 814.9M |
| IPO Year | 1994 | 2008 |
| Metric | BBSI | CYRX |
|---|---|---|
| Price | $32.40 | $15.47 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 8 |
| Target Price | ★ $42.67 | $13.31 |
| AVG Volume (30 Days) | 176.8K | ★ 434.7K |
| Earning Date | 05-06-2026 | 05-04-2026 |
| Dividend Yield | ★ 1.01% | N/A |
| EPS Growth | 5.05 | ★ 156.22 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $920,432,000.00 | $176,177,000.00 |
| Revenue This Year | $6.59 | $11.06 |
| Revenue Next Year | $6.05 | $8.45 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 9.50 | N/A |
| 52 Week Low | $25.33 | $7.61 |
| 52 Week High | $47.51 | $17.20 |
| Indicator | BBSI | CYRX |
|---|---|---|
| Relative Strength Index (RSI) | 38.06 | 46.01 |
| Support Level | $31.89 | $14.55 |
| Resistance Level | $34.98 | $15.60 |
| Average True Range (ATR) | 1.01 | 0.68 |
| MACD | 0.12 | -0.09 |
| Stochastic Oscillator | 17.34 | 12.69 |
Barrett Business Services Inc is a provider of business management solutions for small and mid-sized companies through a platform that combines management consulting expertise with human resource tools to help business owners manage and operate their businesses more effectively. The company has two categories of services: Professional Employer Services (PEO) and Staffing. The majority of revenue is derived from the Professional Employer Services segment, which provides clients with human resource advisory services, HRIS access, retirement plans, a learning management system, and a web-based technology platform, myBBSI.
CryoPort Inc is a provider of integrated, temperature-controlled supply chain solutions for the life sciences industry, with a focus on supporting the cell and gene therapy market. The company provides services such as temperature-controlled logistics, biostorage, bioservices, cryopreservation solutions, and cryogenic systems manufacturing. It operates through two reportable segments: Life Sciences Services and Life Sciences Products. It generates the majority of its revenue from the Life Sciences Services segment.